Tusamitamab-MMAE is an antibody-drug conjugate (ADC) that combines a CEACAM5-targeted antibody with Monomethyl auristatin E (MMAE), designed for research in non-small cell lung cancer.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted